Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy Adults
Condition: Healthy AdultsInterventions: Drug: TNX-102 SL Tablets at 2.8 mg; Drug: TNX-102-B SL Tablets at 2.8 mg; Drug: TNX-102-C SL Tablets at 2.8 mg; Drug: Cyclobenzaprine tabletsSponsor: Tonix Pharmaceuticals, Inc.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2013 Category: Research Source Type: clinical trials
Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults
Condition: Healthy AdultsInterventions: Drug: SL TNX-102 2.4 mg at pH 3.5; Drug: SL TNX-102 2.4 mg at pH 7.1; Drug: Cyclobenzaprine Tablet; Drug: Cyclobenzaprine IVSponsor: Tonix Pharmaceuticals, Inc.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2012 Category: Research Source Type: clinical trials
A Randomized Study of Three Medication Regimens for Acute Low Back Pain
Condition: Acute Low Back PainInterventions: Drug: Naproxen; Drug: Cyclobenzaprine; Drug: Oxycodone/ acetaminophenSponsor: Montefiore Medical CenterActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2012 Category: Research Source Type: clinical trials
Comparative Bioavailability of TNX-102 and Cyclobenzaprine and Effect of Food on the Pharmacokinetics of TNX-102 in Healthy Adults
Condition: HealthyInterventions: Drug: TNX-102 2.4 mg, Fasting conditions; Drug: TNX-102 2.4 mg, Fed conditions; Drug: Cyclobenzaprine 5 mg, Fasting conditionsSponsor: Tonix Pharmaceuticals, Inc.Completed - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2011 Category: Research Source Type: clinical trials
